[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.211.41.181. Please contact the publisher to request reinstatement.
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]
Article
April 1985

Oxidation-Reduction Maintenance in Organ Preservation

Author Affiliations

From the Departments of Surgery (Drs Jellinek, Garvin, and Codd and Mr Niehoff) and Biochemistry (Dr Jellinek), St Louis University Medical School, and the Department of Surgery, John Cochran Veterans Administration Hospital, St Louis (Dr Castaneda).

Arch Surg. 1985;120(4):439-442. doi:10.1001/archsurg.1985.01390280033008
Abstract

• The isolated perfused organ is more sensitive to the toxicity of oxygen since hypothermia reduces the activities of enzymes responsible for minimizing oxygen toxicity. To protect the organ under these conditions reducing agents must be added to the perfusate. Quantitation of the resulting reduction is best obtained by measurement of the oxidation-reduction potential of the perfusate. A device was designed for this purpose and, by electrochemical principle, controlled reduction of the oxidized form of the oxidation-reduction couple was affected. Kidneys were perfused with cryoprecipitated plasma. With the electrochemical cell in the circuit, the oxidation-reduction potential of the perfusate was adjusted by the addition of ascorbic acid and glutathione and the cell was driven by a battery-powered potentiostat. Kidneys subjected to 60 minutes of warm ischemia had optimal survival at–20 mV. Preservation for six days in a monitored group had no survivors, whereas kidneys with oxidation-reduction support maintained life. Optimal oxidation-reduction was at or near—17 mV. These data show a requirement of an optimal oxidation-reduction potential to reverse warm ischemia damage and to prolong the period of ex vivo preservation of isolated perfused organ.

(Arch Surg 1985;120:439-442)

References
1.
Terasaki PI, Perdue ST, Sasaki N, et al:  Improving success rates of kidney transplantation . JAMA 1983;250:1065-1068.Article
2.
Toledo-Pereyra LH:  Organ preservation . J Surg Res 1981;30:181-190.Article
3.
Parker RC: Methods of Tissue Culture . New York, Paul B Hoeber Inc, 1938.
4.
Barron ESG, Singer TP:  Enzyme systems containing active sulfhydryl groups: The role of glutathione . Science 1943;97:356-358.Article
5.
Jellinek M, Hahn JW, Layloff TP, et al:  Electrochemical control of redox potential in perfusate for prolonged heart storage . Trans Am Soc Artif Intern Organs 1974;20:533-537.
6.
Codd JC, Jellinek M, Garvin PG, et al:  Redox maintenance in restoration of organ viability . J Surg Res 1977;22:585-592.Article
7.
Codd JE, Jellinek M, Garvin PG, et al:  Redox maintenance and organ preservation . Transplant Proc 1977;9:1569-1571.
8.
Bry WI, Collins GM, Halasz NA, et al: Improved Function of Perfused Rabbit Kidneys by Prevention of Oxidation Injury . Presented to the American Society of Transplant Surgeons, Tenth Annual Scientific Meeting, Chicago, (May 31) , 1984.
9.
Fahy GM, Homblower M, Williams H:  An improved perfusate for hypothermic renal preservation: I. Initial in vitro optimization based on tissue electrolyte transport . Cryobiology 1979;16:618.Article
10.
Belzer FO, Glass NR, Sollinger HW:  A new perfusate for kidney preservation . Transplantation 1982;33:322-323.
11.
Jellinek M, Codd JE:  A new electrode material for perfusion redox control . Trans Seventh Ann Meet Soc Biomaterials 1981;4:27.
12.
Belzer FO, Ashby BS, Dunphy JE:  Twenty-four to 72-hour preservation of canine kidneys . Lancet 1967;2:536-539.Article
13.
Shlafer M, Kane P, Kirsh M:  Superoxide desmutase plus catalase enhances the efficiency of hypothermic cardioplegia to protect the globally ischemic reperfused heart . J Thorac Cardiovasc Surg 1982;83:830-839.
14.
Parks DA, Bulkley GB, Granger DN:  Role of oxygen-free radicals in shock, ischemia, and organ preservation . Surgery 1983;94:428-431.
15.
Faiman MD, Mehl RG, Oehme FW:  Protection with disulfiram from central and pulmonary oxygen toxicity . Biochem Pharmacol 1971;20: 3059-3067.Article
16.
Harris JW:  Binding of sulfhydryl reagents to normal and irradiated leucocyte lysosomes . Aust J Exp Biol Med Sci 1968;46:209-217.Article
17.
Haugaard N:  Cellular mechanisms of oxygen toxicity . Physiol Rev 1968;48:311-373.
18.
Shapiro HA:  Redox balance in the body and approach to quantitation . J Surg Res 1972;3:138-152.Article
×